肝动脉化疗栓塞结合经皮肝穿刺瘤内注射醋酸治疗原发性肝癌的疗效观察

目的　观察肝动脉化疗栓塞 (TACE)结合B超引导下经皮肝穿瘤内注射 30 %醋酸 (PAI)治疗原发性巨块型肝癌的临床疗效。方法　对 2 3例中、晚期巨块型肝癌均先采用TACE ,术后 15～ 2 0d再在B超引导下PAI 2～ 3次。结果　治疗 2个周期后比较患者治疗前后AFP降低程度和肿块缩小情况 ,差异有显著性 (P <0 .0 1) ,1、2年生存率分别为 91%和 82 %。结论　TACE结合B超下PAI治疗中、晚期巨块型肝癌有较好的临床疗效。

Transcatheter arterial chemoembolization with combined percutaneous acetic acid injection to cure primary hepatocellular carcinoma:the clinical curative effect

Objective To observe the clinical curative effect of transcatheter arterial chemoembolization (TACE) in combination with 30% percutaneous acetic acid injection (PAI) under B-ultrasonic guidance to cure primary massive hepatocellular carcinoma. Methods Twinty three patients with intermediate or advanced stage of massive hepatocellular carcinomas were undergone transcatheter arterial chemoembolization. After 15-20 days, 30% percutaneous acetic injection was done for 2-3 times under B-ultrasonic guidance. Results After 2-3 periods of treatment, a significant difference (P<0.01) was revealed by comparing AFP decrease and tumor mass reducation. The survival rate for one or two years was 91% and 82% respectively. Conclusions We found a relatively good clinical curative effect for intermediate and advanced massive hepatocellular carcinoma by using combined with PAI under B-ultrasonic guidance.